• Leeds Beckett University Featured Masters Courses
  • University of York Featured Masters Courses
  • University of Edinburgh Featured Masters Courses
  • Regent’s University London Featured Masters Courses
  • Imperial College London Featured Masters Courses
  • Xi’an Jiaotong-Liverpool University Featured Masters Courses
  • Swansea University Featured Masters Courses
University of Lincoln Featured Masters Courses
Institute for Advanced Architecture of Catalonia Featured Masters Courses
University of Leeds Featured Masters Courses
University of Kent Featured Masters Courses
Newcastle University Featured Masters Courses
"cancer" AND "treatment"×
0 miles

Masters Degrees (Cancer Treatment)

  • "cancer" AND "treatment" ×
  • clear all
Showing 1 to 15 of 111
Order by 
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. Read more
The Cancer MSc reflects the depth and breadth of research interests, from basic science to translational medicine, within the UCL Cancer Institute. The programme, taught by research scientists and academic clinicians, provides students with an in-depth look at the biology behind the disease processes which lead to cancer.

Degree information

This programme offers a foundation in understanding cancer as a disease process and its associated therapies. Students learn about the approaches taken to predict, detect, monitor and treat cancer, alongside the cutting-edge research methods and techniques used to advance our understanding of this disease and design better treatment strategies.

Students undertake modules to the value of 180 credits. The programme consists of two core modules (60 credits), four specialist modules (60 credits) and a research project (60 credits). A Postgraduate Diploma (120 credits, full-time nine months) is offered. A Postgraduate Certificate (60 credits, full-time 12 weeks) is offered.

Core modules
-Basic Biology and Cancer Genetics
-Cancer Therapeutics

Specialist modules
-Behavioural Science and Cancer
-Biomarkers in Cancer
-Cancer Clinical Trials
-Haematological Malignancies and Gene Therapy

Dissertation/report
All MSc students undertake a laboratory project, clinical trials project or systems biology/informatics project, which culminates in a 10,000–12,000 word dissertation and an oral research presentation.

Teaching and learning
Students develop their knowledge and understanding of cancer through lectures, self-study, database mining, wet-lab based practicals, clinical trial evaluations, laboratory training, assigned reading and self-learning. Each taught module is assessed by an unseen written examination and/or coursework. The research project is assessed by the dissertation (75%) and oral presentation (25%).

Careers

The knowledge and skills developed will be suitable for those in an industrial or healthcare setting, as well as those individuals contemplating a PhD or medical studies in cancer.

Top career destinations for this degree:
-Research Technician, NHS Imperial College Healthcare NHS Trust
-Cancer and Genetics, ETH Zurich
-PhD Cancer Research, University of New South Wales (UNSW)
-Clincial Trial Project Manager, Beijing Lawke Health Laboratory Inc.
-Research Scientist, SporeGen

Employability
Skills include critical evaluation of scientific literature, experimental planning and design interpretation of data and results, presentation/public speaking skills, time management, working with a team, working independently and writing for various audiences.

Why study this degree at UCL?

UCL is one of Europe's largest and most productive centres of biomedical science, with an international reputation for leading basic, translational and clinical cancer research.

The UCL Cancer Institute brings together scientists from various disciplines to synergise multidisciplinary research into cancer, whose particular areas of expertise include: the biology of leukaemia, the infectious causes of cancer, the design of drugs that interact with DNA, antibody-directed therapies, the molecular pathology of cancer, signalling pathways in cancer, epigenetic changes in cancer, gene therapy, cancer stem cell biology, early phase clinical trials, and national and international clinical trials in solid tumours and blood cancers.

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of treating cancer.

This will be underpinned by a thorough knowledge of cancer biology and pathology and research methodologies.

This knowledge will provide an excellent grounding in the development, use and evaluation of cancer therapies, which will enhance career prospects in many areas of early phase clinical trials and clinical drug development in the cancer setting.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Molecular Diagnostic & Therapeutics
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Genomic Approaches to Human Diseases
• Paediatric & Adolescent Oncology
• Pathology of Cancer

Core Module for MSc

• Dissertation.

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

Find out more about the BCI at http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research. Read more
This programme aims to provide you with a clear understanding of molecular and cellular biology that is fundamental to cancer biology and cancer research.

You will learn how research in this area has advanced the treatment and diagnoses of cancer, and gain knowledge of how new therapies are developed, evaluated and implemented.

You will gain a thorough knowledge of research methodologies and laboratory techniques, which you will fully utilise in the laboratory research project stage. The valuable research experience you will gain from working with leading cancer experts, will give you a solid foundation upon which a future career in scientific research can be built.

Compulsory Modules

• Biological Therapies
• Cancer Biology
• Cancer Pharmacology
• Drug Development
• Genomic Approaches to Human Diseases
• Molecular Diagnostic & Therapeutics
• Pathology of Cancer
• Research Lab Skills
• Research Methods

Elective Modules

• Cancer Prevention & Screening
• Paediatric & Adolescent Oncology

Core Module for MSc

• Lab project


Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, our programmes are all taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments. Read more
This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of clinical oncology and the development, evaluation and implementation of new treatments.

This will be underpinned by a thorough knowledge of cancer biology and pathology, drug development and research methodologies.

This knowledge will provide you with a good grounding in oncology within a clinical setting which will enhance prospects for those wanting to pursue a clinical academic career.

Compulsory Modules

• Ablative Therapies
• Cancer Biology
• Cancer Pharmacology
• Cancer Prevention & Screening
• Drug Development
• Genomic Approaches to Human Diseases
• Imaging
• Paediatric & Adolescent Oncology
• Pathology of Cancer
• Research Methods
• Site Specific Tumour Treatment

Elective Modules

• Biological Therapies
• Molecular Targeted Therapies and Immunotherapy for Blood Cancer

Core Module for MSc

• Dissertation

Barts Cancer Institute is a Cancer Research UK Centre of Excellence and one of the leading cancer institutes in the country.
Based in the heart of London, all our programmes are taught by experts in the field.

To find out more about BCI visit http://www.bci.qmul.ac.uk/study-with-us

Read less
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Read more
The area of cancer immunotherapy considers how to use conventional therapies including surgery, radiation and chemotherapy. Whilst these treatment have served well and new drugs will continue to be designed, clinical trials over the last five years have shown that boosting the body’s immune system, whose main task is to deal with invading pathogens, can help our immune system to destroy tumour cells. Many of the new immunotherapies may be tested in combination with more conventional treatments or tested alone, but investigators and oncologists now believe immunotherapy, initially combined with pharmacological treatments, will soon provide curative therapies and certainly give many patients a new lease of life.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of the Cancer Immunotherapy MSc are to:
-Provide an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data
-Deliver a programme of advanced study to equip students for a future career in anti-cancer drug and immunotherapy development
-Cover new areas in immunotherapy (some of which may enhance existing pharmacological therapies including: History of immunotherapy and review of immune system; Monoclonal antibodies in cancer therapy and prevention; DNA vaccines against cancer; Adoptive T cell therapy; Dendritic cell vaccines; Antibodies that stimulate immunity; Adjuvant development for vaccines; Epigenetics and cancer: improving immunotherapy; Immuno-chemotherapy: integration of therapies; Exosomes and Microvesicles (EMVs) in cancer therapy and diagnosis; Dendritic cell vaccine development and Pox virus cancer vaccine vectors; Microbial causes of cancer and vaccination

Students will have access to highly qualified researchers and teachers in pharmacology and immunology, including those at the Cellular and Molecular Immunology Research Centre. Skills gained from research projects are therefore likely to be highly marketable in industry, academia and in the NHS. Students will be encouraged to join the British Society of Immunology and the International Society of Extracellular Vesicles.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Advanced Immunology (core, 20 credits)
-Cancer Immunotherapy (core, 20 credits)
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)

After the course

Students will have many opportunities to work in industry. There are established industries working hard to develop cancer immunotherapies including Bristol-Myers Squibbs, MERCK, AstraZeneca and Roche. There are also an innumerate number of start-up companies appearing including Omnis Pharma, UNUM Therapeutics and Alpine Immune Sciences.

Students will also have ample opportunity for future postgraduate study either within the School of Human Sciences and the Cellular and Molecular Immunology Centre at the MPhil/PhD level or beyond, even with some of our research partners within the UK, Europe and beyond.

Read less
Therapeutic radiographers use sophisticated radiography equipment to treat patients suffering from cancer or non-malignant tumours by aiming doses of radiation at tumours. Read more
Therapeutic radiographers use sophisticated radiography equipment to treat patients suffering from cancer or non-malignant tumours by aiming doses of radiation at tumours. With an increasing amount of opportunities available for therapeutic radiographers, prospects for graduates are very bright.

In the treatment of cancer, accuracy is paramount and a variety of highly specialised equipment is available within Radiotherapy Departments to achieve this. Computerised Tomography (CT) simulators employ the latest technology to localise tumours. Technological advances in linear accelerator design ensure that treatment conforms to patients needs with pinpoint accuracy. Treatment units housing radioactive sources also play a useful role in patient management, as do 3D planning systems.

Alongside the technology, the importance of high standards of communication and care of cancer patients cannot be overestimated. Cancer patients are treated by a multidisciplinary team in which the therapeutic radiographer plays a major role in reducing the sense of vulnerability and promoting patients autonomy.

Therapeutic Radiographers work within a multidisciplinary team in Radiation Oncology and play a vital role in the management and treatment of patients with cancer. They are predominantly responsible for treatment for the accurate localisation, planning and delivery of ionising radiation

The PgDip programme compliments the changing healthcare environment with the aim of providing practitioners who are fit for purpose and fit for award and is an accelerated programme over two years, for graduate students who already have a level 6 qualification. Building on graduate skills you will develop an enquiring, reflective, critical and innovative approach to Therapeutic Radiography within the context of the rapid changes occurring in the health service.

The programme aims to develop confident and competent practitioners who practice autonomously, compassionately, skilfully and safely whilst fostering independence in learning and commitment to lifelong learning. The course comprises of five compulsory units instilling a range of academic knowledge from health sciences to profession specific radiotherapy and oncology practice.

The PgDip in Therapeutic Radiography confers eligibility to apply for registration with the Health and Care Professions Council (HCPC) as a Radiographer.

See the website http://www.lsbu.ac.uk/courses/course-finder/therapeutic-radiography-pre-registration-pgdip-msc

Modules

Year 1:
- Radiation science and technology
This module provides the basic physical concepts of the production, detection and interaction of ionising radiations and the importance of safe working practices.

- Applied biological sciences
This module provides an understanding of anatomy and pathophysiology with an introduction to oncology and the concept of holistic care in the management of people with cancer, with reference to evidence based practice.

- Clinical radiotherapy theory and practice 1
This module introduces the professional practice of radiotherapy. It identifies the various radiotherapy modalities employed in the treatment of people with cancer. This module will also complement the knowledge and learning gained within clinical practice by focussing on the acquisition of basic skills required for the safe, accurate planning and treatment of patients with cancer.

Year 2:
- Management of morbidities
This module addresses the principles of radiobiology and cytotoxic chemotherapy, to facilitate appreciation of the limiting effects of normal tissues on treatment. Methods of limiting radiation and cytotoxic morbidity, together with the wider issue of palliative care will also be considered.

- Clinical radiotherapy theory and practice 2
This module provides knowledge and skills relevant to pre-treatment and verification processes employed in the radiotherapy management of patients. You will be required to develop a critical awareness of advances in technology and practice. Clinically based competencies focus on the complex techniques found in Radiotherapy and the problem solving skills required for successful performance in clinical practice.

Employability

- Radiotherapy as a career
On successful completion of the course you'll be eligible to register with the Health and Care Professions Council (HCPC) as a therapeutic radiographer.

From helping plan and administering treatment, to explaining it to patients and assessing their responses, therapeutic radiographers are involved in every stage of the treatment process.

Therapeutic radiographers need excellent interpersonal skills and emotional resilience as they deal with patients and their families at very difficult and emotional times. Making patients feel comfortable and guiding them through the process can be as important as the technical skills required for this role.

- Career progression
Through the acquisition of a wide range of transferable skills such as psychosocial, organisational, management, technical and scientific skills, individuals are well prepared to work in any situation that best suits their individual expertise and interest.Working as a consultant practitioner is one common career path as well as management, research, clinical work and teaching.

After qualification, clinically experienced therapeutic radiographers may gain additional specialist skills and expertise through the postgraduate, post-registration and continuing professional development frameworks.

LSBU Employability Services

LSBU is committed to supporting you develop your employability and succeed in getting a job after you have graduated. Your qualification will certainly help, but in a competitive market you also need to work on your employability, and on your career search. Our Employability Service will support you in developing your skills, finding a job, interview techniques, work experience or an internship, and will help you assess what you need to do to get the job you want at the end of your course. LSBU offers a comprehensive Employability Service, with a range of initiatives to complement your studies, including:

- direct engagement from employers who come in to interview and talk to students
- Job Shop and on-campus recruitment agencies to help your job search
- mentoring and work shadowing schemes.

Placements

- Time spent on placement
Clinical placements are an essential element of the course. You will spend 50% of your time involved in academic study and 50% in clinical practice within a broad variety of healthcare settings. A clinical practice placement allows you to put theory into practice by working with a range of health professionals in clinical situations to develop the skills, knowledge and experience required to become a competent radiographer. Although sometimes initially challenging, practice learning is one of the most interesting and exciting aspects of learning to be a radiographer.

- Clinical settings
At LSBU you will experience a variety of clinical settings such as NHS Trusts and the independent sector.

Placements for Therapeutic Radiography include:
- Brighton and Sussex University Hospital: Sussex Cancer Centre
- Maidstone and Tunbridge Wells NHS Trust: Kent Oncology Centre
- Guy's and St Thomas' NHS Foundation Trust
- Royal Surrey Hospital
- Queens Hospital, Romford

- Structure of placements
Placements are spread over two years.

The first clinical placement; approximately seven weeks after the start of the course, gives a real taster of the role of the radiotherapy radiographer in the radiotherapy treatment process. It gives you an opportunity to confirm correct choice of career early within the course. Thereafter clinical placements follow the same pattern throughout the course.

Support from a mentor

An identified Link Lecturer and Personal Tutor from the University will be the person you can contact during working day hours whilst on placement with any concerns or questions you are unable to solve otherwise. As there is a close relationship between LSBU and the clinical placement; the Link Lecturer will pay regular scheduled visits to the different sites to meet up with students.

Read less
This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Read more
This Masters in Cancer Sciences will prepare you for a career in cancer science, whether you aim to pursue a PhD or further medical studies, or seek a career in the health services sector, in the life sciences, biotechnology or pharmaceutical industries. Our programme takes a “bench to bedside” approach, enabling graduates to work within a multidisciplinary environment of world-leading scientists and cancer-specialists to address the latest challenges in cancer research.

Why this programme

-University of Glasgow is rated in the UK top five and best in Scotland for Cancer Studies. You will be taught by a multidisciplinary team of world leading cancer scientists and clinicians within the Cancer Research UK Glasgow Centre.
-This MSc in Cancer Science programme is unique in the UK as it delivers integrated teaching in molecular biology, pathology and clinical service.
-The Cancer Research UK Glasgow Centre brings together scientists and clinicians from research centres, universities and hospitals around Glasgow to deliver the very best in cancer research, drug discovery and patient care. The Centre’s world leading teams have made major advances in the understanding and treatment of many cancers. For more information, please visit: http://www.wecancentre.org/
-In the first semester, each week is focused around one of the new Hallmarks of Cancer, with the focus on the molecular/cellular biology of this hallmark. A tutorial session will enable you to discuss and integrate your learning from the week. This will enable you to understand how research into the fundamental principles of cancer cell biology can translate to advances in cancer treatment.
-The aim of this MSc in Cancer Science is to train cancer researchers who can break down the barriers that currently prevent discoveries at the bench from being translated into treatments at the bedside. By understanding the science, methodology and terminology used by scientists and clinicians from different disciplines, you will learn to communicate effectively in a multidisciplinary environment, critically evaluate a wide range of scientific data and research strategies and learn how to make a significant contribution to cancer research.

Semester 1
-Hallmarks of Cancer

Semester 2
-Drug Discovery
-Drug Development and Clinical trials
-Viruses and Cancer
-Diagnostic technologies and devices
-Technology transfer and commercialisation of bioscience research
-Current trends and challenges in biomedical research and health
-Frontiers in Cancer Sciences
-Omic technologies for the biomedical sciences: from genomics to metabolomics
-Designing a research project: biomedical research methodology

Semester 3
-Bioscience Research Project

Programme aims

We will lead you through the molecular and cellular hallmarks of cancer biology, including genetic instability, cancer growth and invasion, tumour-stroma interactions, immune response to cancer, cancer metabolism, and cancer stem cells, and explain how this knowledge is being used in our fight against cancer.

You will experience how to plan and write a project proposal and report, and how to research, evaluate, and critically discuss scientific data and present these to a wider audience. A 14-week long research project will finally allow you to gain in-depth knowledge in a cancer-related area of your interest. This programme will therefore give you an excellent foundation for your future career in cancer science.

We will lead you through the molecular and cellular hallmarks of cancer biology and metastasis formation, including genetic instability, cancer growth and invasion, tumour-stroma interactions, immune response to cancer, cancer metabolism, and cancer stem cells, and explain how this knowledge is being used in our fight against cancer in our clinics by providing a personalised cancer treatment. The programme will allow you to specialize either on the molecular aspects of cancer science, including genome wide data analysis for the characterization and classification of cancers, or learn about cutting edge translational cancer research, and introduce you to drug discovery pipelines and clinical trials.

You will experience how to plan and write a project proposal and report, and how to research, evaluate, and critically discuss scientific data and present these to a wider audience. A 14-week long research project will finally allow you to gain in-depth knowledge in a cancer-related area of your interest. This programme will therefore give you an excellent foundation for your future career in cancer science.

Career prospects

The knowledge and transferable skills developed in this programme will be suitable for those contemplating a PhD or further medical studies; those wishing to work in the health services sector; and those interested in working in the life sciences, biotechnology or pharmaceutical industries, including contract research organisations (CROs). This programme is designed for students with undergraduate degrees in the life sciences, scientists working in the pharmaceutical and biotechnology industries, and clinicians and other healthcare professionals.

Read less
This unique course will provide you with comprehensive, up-to-date information, while exploring key developments in the field (moving from hospital-based follow-up to self-management, etc). Read more
This unique course will provide you with comprehensive, up-to-date information, while exploring key developments in the field (moving from hospital-based follow-up to self-management, etc). It is aimed at anybody who has practical involvement and/or interest in dealing with people affected by cancer.

Our strong and growing links with local, national and international agencies will help you develop a critical and reflective approach to working with this growing population.

The course is delivered online via our virtual learning environment which means you study from anywhere in the world.

Depending on the number of credits you accrue, you can achieve either a PgCert or Single Module:

• PgCert (60 credits)
• Single Module (30 credits)

Key benefits:

• Obtain a better understanding of the long-term impact of cancer diagnosis and treatment on individuals and their families
• Gain an overview of the cultural shift in the approach to care and support for people living with and beyond cancer
• Enjoy opportunities to interact with a variety of health and social care practitioners

Visit the website: http://www.salford.ac.uk/pgt-courses/cancer-survivorship

Suitable for

Health and social care professionals working with people affected by cancer.
Employers, managers, trade unionists, etc. who have either direct experience or interest in the support of this group

Programme details

On the course, you will:

• Critically appraise the complex issues associated with cancer survivors and their families.
• Gain the appropriate knowledge and skills to adjust to the cultural shift in the approach to care and support for people living with and • beyond cancer.
• Have the comprehensive knowledge, skills and abilities to evaluate research which underpins cancer survivorship.

Format

Both modules are delivered online through our virtual learning environment, Blackboard, and online class-room, Collaborate. Blackboard allows you to access learning materials, participate in discussion boards and webinars, and access recommended reading lists. The vast majority of this recommended reading is available through the library in electronic form.

Online lectures are delivered by subject experts via Collaborate and recorded for future use. Where appropriate experienced practitioners and clients may also join online sessions or get involved via video.

Module titles

• The impact of cancer and its treatment
• Support to live with and beyond cancer

Assessment

You will be assessed through

• Essay (100%)

Career potential

Health and social care practitioners who obtain this qualification may use it as a credential for promotion within their organisation.

How to apply: http://www.salford.ac.uk/study/postgraduate/applying

Read less
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population. Read more
The MSc in Cancer Biology is for students who wish to gain an advanced education and training in the biological sciences, within the context of a disease that affects a large proportion of the global population.

The programme provides training in the modern practical, academic and research skills that are used in academia and industry. Through a combination of lectures, small-group seminars and practical classes, students will apply this training towards the development of new therapies.

The programme culminates with a research project that investigates the molecular and cellular basis of cancer biology or the development of new therapies under the supervision of active cancer research scientists.

Visit the website: https://www.kent.ac.uk/courses/postgraduate/226/cancer-biology

About the School of Biosciences

The School of Biosciences is among the best-funded schools of its kind in the UK, with current support from the BBSRC, NERC, MRC, Wellcome Trust, EU, and industry. It has 38 academic staff, 56 research staff (facility managers, research fellows, postdoctoral researchers and technicians), approximately 100 postgraduate students and 20 key support staff. The school's vibrant atmosphere has expanded to become a flourishing environment to study for postgraduate degrees in a notably friendly and supportive teaching and research environment.

Research in the School of Biosciences revolves around understanding systems and processes in the living cell. It has a strong molecular focus with leading-edge activities that are synergistic with one another and complementary to the teaching provision. Our expertise in disciplines such as biochemistry, microbiology and biomedical science allows us to exploit technology and develop groundbreaking ideas in the fields of genetics, molecular biology, protein science and biophysics. Fields of enquiry encompass a range of molecular processes from cell division, transcription and translation through to molecular motors, molecular diagnostics and the production of biotherapeutics and bioenergy.

In addition to research degrees, our key research strengths underpin a range of unique and career-focused taught Master’s programmes that address key issues and challenges within the biosciences and pharmaceutical industries and prepare graduates for future employment.

Course structure

Each one-hour lecture is supplemented by two hours of small-group seminars and workshops in which individual themes are explored in-depth. There are practical classes and mini-projects in which you design, produce and characterise a therapeutic protein with applications in therapy.

In additional to traditional scientific laboratory reports, experience will be gained in a range of scientific writing styles relevant to future employment, such as literature reviews, patent applications, regulatory documents, and patient information suitable for a non-scientific readership.

Modules

The following modules are indicative of those offered on this programme. This list is based on the current curriculum and may change year to year in response to new curriculum developments and innovation. Most programmes will require you to study a combination of compulsory and optional modules. You may also have the option to take modules from other programmes so that you may customise your programme and explore other subject areas that interest you.

BI830 - Science at Work (30 credits)
BI836 - Practical and Applied Research Skills for Advanced Biologists (30 credits)
BI837 - The Molecular and Cellular Basis of Cancer (15 credits)
BI838 - Genomic Stability and Cancer (15 credits)
BI840 - Cancer Therapeutics: From the Laboratory to the Clinic (15 credits)
BI857 - Cancer Research in Focus (15 credits)
BI845 - MSc Project (60 credits)

Assessment

The programme features a combination of examinations and practically focused continuous assessment, which gives you experience within a range of professional activities, eg, report writing, patent applications and public health information. The assessments have been designed to promote employability in a range of professional settings.

Programme aims

This programme aims to:

- provide an excellent quality of postgraduate-level education in the field of cancer, its biology and its treatment

- provide a research-led, inspiring learning environment

- provide a regional postgraduate progression route for the advanced study of a disease that affects a high proportion of the population

- promote engagement with biological research into cancer and inspire you to pursue a scientific career inside or outside of the laboratory

- develop subject specific and transferable skills to maximise employment prospects

- promote an understanding of the impact of scientific research on society and the role for scientists in a range of professions.

Research areas

Research in the School of Biosciences is focused primarily on essential biological processes at the molecular and cellular level, encompassing the disciplines of biochemistry, genetics, biotechnology and biomedical research.

The School’s research has three main themes:

- Protein Science – encompasses researchers involved in industrial biotechnology and synthetic biology, and protein form and function

- Molecular Microbiology – encompasses researchers interested in yeast molecular biology (incorporating the Kent Fungal Group) and microbial pathogenesis

- Biomolecular Medicine – encompasses researchers involved in cell biology, cancer targets and therapies and cytogenomics and bioinformatics.

Each area is led by a senior professor and underpinned by excellent research facilities. The School-led development of the Industrial Biotechnology Centre (IBC), with staff from the other four other schools in the Faculty of Sciences, facilitates and encourages interdisciplinary projects. The School has a strong commitment to translational research, impact and industrial application with a substantial portfolio of enterprise activity and expertise.

Careers

A postgraduate degree in the School of Biosciences is designed to equip our graduates with transferable skills that are highly valued in the workplace. Our research-led ethos ensures that students explore the frontiers of scientific knowledge, and the intensive practical components provide rigorous training in cutting edge technical skills that are used in the modern biosciences while working in areas of world-leading expertise within the School.

Destinations for our graduates include the leading pharmaceutical and biotechnological companies within the UK and leading research institutes both at home and abroad.

Find out how to apply here - https://www.kent.ac.uk/courses/postgraduate/apply-online/226

Read less
The Master of Cancer and Haematology Nursing aims to assist nurses who care for people affected by cancer and haematological illness to develop their knowledge and skills for their care. Read more
The Master of Cancer and Haematology Nursing aims to assist nurses who care for people affected by cancer and haematological illness to develop their knowledge and skills for their care. You will investigate the biology of cancer and haematology, associated treatments, and integrated multidisciplinary management. You will acquire knowledge about all aspects of the prevention, diagnosis and management of cancer, future treatment trends and the exploration of the impact of these illnesses on the individual, family and community. With the increasing trends towards both home-based care and towards intensive treatments such as Stem Cell Transplantation, the course provides a broad range of content across a diverse spectrum of cancer and haematology care and explores broadening roles for nurses in cancer and haematology care. Nursing interventions to reduce the impact of cancer and its treatment are addressed, drawing on research and the theoretical underpinnings of cancer and haematology care.

To ask a question about this course, visit http://sydney.edu.au/internationaloffice/

Read less
The Cancer Sciences MRes is a one year, full time programme introduced to offer postgraduate training to suitably qualified science students who are interested in research careers in cancer. Read more
The Cancer Sciences MRes is a one year, full time programme introduced to offer postgraduate training to suitably qualified science students who are interested in research careers in cancer. It is a stand-alone programme that would be of particular interest to students who wish to apply for further training at PhD level.

Designed to offer life and biomedical science graduates the opportunity to gain research training through practical experience in a leading cancer research centre.

The programme consists of three introductory taught modules and an extensive project within a research group in the School of Cancer Sciences. The lecture modules will be taught by leading cancer experts and will cover such topics as the cellular and molecular basis of cancer, the pathology of selected cancers and how translational research is applied to diagnosis and treatment of cancers. The projects will generally be laboratory-based and will provide skills in designing and implementing research strategies to answer fundamental questions relating to cancer causes, diagnosis and/or treatment.

About the College of Medical and Dental Sciences

The College of Medical and Dental Sciences is a major international centre for research and education, make huge strides in finding solutions to major health problems including ageing, cancer, cardiovascular, dental, endocrine, inflammatory diseases, infection (including antibiotic resistance), rare diseases and trauma.
We tackle global healthcare problems through excellence in basic and clinical science, and improve human health by delivering tangible real-life benefits in the fight against acute and chronic disease.
Situated in the largest healthcare region in the country, with access to one of the largest and most diverse populations in Europe, we are positioned to address major global issues and diseases affecting today’s society through our eight specialist research institutes.
With over 1,000 academic staff and around £60 million of new research funding per year, the College of Medical and Dental Sciences is dedicated to performing world-leading research.
We care about our research and teaching and are committed to developing outstanding scientists and healthcare professionals of the future. We offer our postgraduate community a unique learning experience taught by academics who lead the way in research in their field.

Funding and Scholarships

There are many ways to finance your postgraduate study at the University of Birmingham. To see what funding and scholarships are available, please visit: http://www.birmingham.ac.uk/pgfunding

Open Days

Explore postgraduate study at Birmingham at our on-campus open days.
Register to attend at: http://www.birmingham.ac.uk/pgopendays

Virtual Open Days

If you can’t make it to one of our on-campus open days, our virtual open days run regularly throughout the year. For more information, please visit: http://www.pg.bham.ac.uk

Read less
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. Read more
This exciting new course is designed to equip future scientists with the knowledge to make a difference in the understanding and treatment of cancer. The course will take the mechanistic understanding of cancer biology and apply it to the analysis of risk, prevention, diagnosis, prognosis and therapy. Building on a foundation of the understanding of basic cancer cell biology, translational coverage will consider design of treatment modalities, mechanisms of action of anti-cancer drugs, therapy resistance and biomarker discovery. The course will allow the students to gain expertise and knowledge in therapy, cancer chemoprevention, anti-cancer target discovery, clinical trials, imaging, cancer risk and epidemiology and biostatistics. A key component of the course is a five/six-month research project, which will give students an opportunity to study one of these areas in depth.

Read less
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work. Read more
The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:
-Provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
-Review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
-Enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.

Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

The modules listed below are for the academic year 2016/17 and represent the course modules at this time. Modules and module details (including, but not limited to, location and time) are subject to change over time.

Year 1 modules include:
-Cancer Pharmacology (core, 20 credits)
-Cancer: Diagnosis and Therapy (core, 20 credits)
-Medical Genetics (core, 20 credits)
-Molecular Oncology (core, 20 credits)
-Research Project (core, 60 credits)
-Scientific Frameworks for Research (core, 20 credits)
-Advanced Drug Formulation Technologies (option, 20 credits)
-Bioinformatics and Molecular Modelling (option, 20 credits)
-Drug Discovery Technology (option, 20 credits)

After the course

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or study.

Moving to one campus

Between 2016 and 2020 we're investing £125 million in the London Metropolitan University campus, moving all of our activity to our current Holloway campus in Islington, north London. This will mean the teaching location of some courses will change over time.

Whether you will be affected will depend on the duration of your course, when you start and your mode of study. The earliest moves affecting new students will be in September 2017. This may mean you begin your course at one location, but over the duration of the course you are relocated to one of our other campuses. Our intention is that no full-time student will change campus more than once during a course of typical duration.

All students will benefit from our move to one campus, which will allow us to develop state-of-the-art facilities, flexible teaching areas and stunning social spaces.

Read less
If you are a healthcare professional, this course gives you the knowledge and expertise to develop as a specialist prostate cancer practitioner. Read more
If you are a healthcare professional, this course gives you the knowledge and expertise to develop as a specialist prostate cancer practitioner. Through a combination of online learning and (if appropriate) taught study days you learn how to provide, promote and develop high standards of care.

The postgraduate certificate stage focuses on developing your clinical knowledge and skills. The prostate cancer module gives you an in-depth understanding of managing the stages of the disease including:
-The physical and psychosocial impact.
-Treatment.
-The needs of those affected.
-How these needs can be addressed.

As advanced communication is essential to your clinical role, you take one of two modules on the subject. This helps you develop your knowledge of the concepts underpinning advanced communication strategies used in practice. If you choose to take the advanced communication skills in practice module, you have the opportunity to practice your communication skills during intensive role play, the key learning approach.

During the postgraduate diploma stage you develop your understanding of the wider specialist and advanced practice role in areas such as:
-Leadership.
-Peer support.
-Education.
-Service development and improvement.

You also expand your knowledge of high risk or high priority areas in practice such as:
-Care of African Caribbean men.
-Needs relating to sexual function.
-Survivorship.
-End of life care.

This stage of the course also prepares you for undertaking research by improving your understanding of research methods and helping you develop a research question for investigation.

In the final masters stage you research a specific area of interest relevant to your professional role and priorities in practice. This enables you to specialise in your chosen topic, develop expertise and hopefully influence practice or policy.

Throughout your studies you are encouraged to reflect on your role as:
-An ambassador for your patients and their families.
-A peer supporter for other healthcare professionals involved in caring for people affected by the disease.
-An educator.

You also evaluate your own practice and the practice of others to help you develop ideas for service improvement within your practice and workplace.

For more information, see the website: https://www.shu.ac.uk/study-here/find-a-course/mscpgdippgcert-prostate-cancer-care

Course delivery

This is primarily a distance learning course using online learning. You must have internet access and be prepared to engage with technology. We supply you with a range of online learning and teaching resources, including access to library resources and information databases.

Each module provides clear guidance on how to approach your self-directed study. This learning is enhanced by online, tutor facilitated group discussions allowing you to share views and practice experiences with other students. These sessions are a popular and valuable learning resource, and are also used to support you in your final marked assessment.

Professional recognition

Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company number 2653887.

Course structure

Distance learning – 3 years. Starts September and January.

The Postgraduate Certificate (PgCert) is achieved by successfully completing 60 credits. The Postgraduate Diploma (PgDip) is achieved by successfully completing 120 credits. The Masters (MSc) award is achieved by successfully completing 180 credits.

Postgraduate Certificate core modules
-Prostate cancer (15 credits)
-Advanced communication and information in supportive care (30 credits)

Postgraduate Diploma core modules
-Advancing practice in prostate cancer care (30 credits)
-Research methods for practice (15 credits)

Masters
-Dissertation (60 credits)

Optional modules (you choose a further 30 credits from the following modules)
-Loss, grief and bereavement (15 credits)
-Complexities in symptom management (15 credits)
-Collaborative working in supportive care (15 credits)
-Informed consent in healthcare practice (15 credits)
-Evidencing your continuing professional development (15 credits)

Assessment: online activities and discussion; essays; project and research work; presentations.

Read less
Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose. to improve treatment outcomes for patients with cancer. Read more

Programme Overview

Clinicians, scientists and students engaged in cancer research at Newcastle share a common purpose: to improve treatment outcomes for patients with cancer. Work covers a broad spectrum - understanding the biological and molecular differences between normal and malignant cells and using this knowledge to develop new anti-cancer drugs.

Research Supervision

Exploratory biology, target and biomarker discovery
Molecular genetic and mechanistic studies are used to identify critical molecular changes in cancer and their relevance to disease development and progression, and to validate these as biomarkers and targets for therapeutic intervention. A wide range of contemporary genomic, bioinformatic, molecular biology, biochemical and cell biology techniques are used.

Studies focus on haematological malignancies (leukaemia and lymphoma), paediatric solid tumours (neuroblastoma and medulloblastoma), and adult solid tumours (eg breast, ovarian, prostate, bladder and liver cancers).

Drug development
The exploitation of novel targets is achieved by the use of rational drug design, notably the use of structure-based design, in conjunction with medium-throughput screening. Target molecule synthesis and multiple parallel synthesis approaches are used for lead optimisation, and candidate drugs are evaluated in cell-free and whole cell target-based assays.

Biomarker development
We exploit critical molecular defects as biomarkers to enhance disease detection and diagnosis, prediction of disease course, sensitivity to specific drugs and therapeutic monitoring. We play leading roles in molecular diagnostics, biomarker assessment and therapeutic monitoring for national and international clinical trials.

Clinical trials
Clinical trials (Phase I/II/III) are undertaken in both adults and children. Trials have a strong hypothesis-testing translational research component and are performed under the auspices of national or international research networks (eg CR–UK, CCLG, EORTC), as well as directly in collaboration with the pharmaceutical industry.

Training and Skills

As a research student you will receive a tailored package of academic and support elements to ensure you maximise your research and future career. The academic information is in the programme profile and you will be supported by our Faculty of Medical Sciences Graduate School.

For further information see http://www.ncl.ac.uk/postgraduate/courses/degrees/cancer-mphil-phd-md/#training&skills

How to apply

For course application information see http://www.ncl.ac.uk/postgraduate/courses/degrees/cancer-mphil-phd-md/#howtoapply

Read less

Show 10 15 30 per page


Share this page:

Cookie Policy    X